Michelle Springer retweetledi

Could this clinical trial be right for you or someone you know? 💜
@MSKCancerCenter is enrolling participants for a Phase II study of Dostarlimab immunotherapy for people with early-stage dMMR endometrial cancer. Learn more: linktr.ee/JRushFoundation
#EndometrialCancer
English





















